MarketCap
Facebook
X
TelegramAnnual report 2026
added 03-20-2026
Veeva Systems Retained Earnings 2011-2026 | VEEV
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Veeva Systems
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.36 B | 3.45 B | 2.74 B | 2.21 B | 1.73 B | 1.3 B | 920 M | 619 M | 355 M | 212 M | 143 M | 88.9 M | 48.5 M | 24.9 M | 6.14 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.36 B | 6.14 M | 1.21 B |
Quarterly Retained Earnings Veeva Systems
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.12 B | 3.88 B | 3.68 B | 3.26 B | - | - | 2.59 B | 2.46 B | 2.35 B | 1.73 B | 2.03 B | 1.92 B | 1.83 B | 1.3 B | 1.63 B | 1.52 B | 1.42 B | 920 M | 1.2 B | 1.1 B | 1.01 B | 619 M | 853 M | 771 M | 692 M | 389 M | 548 M | 484 M | 434 M | 213 M | 321 M | 287 M | 249 M | 143 M | 190 M | 169 M | 156 M | 88.9 M | 126 M | 115 M | 102 M | 48.5 M | 75.6 M | 65.3 M | 55.8 M | 24.9 M | 42.3 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.12 B | 24.9 M | 1.05 B |
Retained Earnings of other stocks in the Health information services industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-372 M | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
6.75 B | - | - | $ 27.9 B | USA |
 |
HealthEquity
HQY
|
196 M | $ 82.4 | 0.45 % | $ 7.1 B | USA |
 |
Change Healthcare
CHNG
|
-1.1 B | - | - | $ 9.03 B | USA |
 |
Computer Programs and Systems
CPSI
|
8.13 M | - | 4.4 % | $ 133 M | USA |
 |
iCAD
ICAD
|
-277 M | - | - | $ 102 M | USA |
 |
Covetrus
CVET
|
-1.08 B | - | - | $ 2.94 B | USA |
 |
Akerna Corp.
KERN
|
-52.5 M | - | - | $ 161 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-517 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
580 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
301 M | - | - | $ 6.37 B | USA |
 |
Evolent Health
EVH
|
-606 M | $ 3.75 | - | $ 351 M | USA |
 |
GoodRx Holdings
GDRX
|
-1.44 B | $ 2.55 | 8.05 % | $ 984 M | USA |
 |
10x Genomics
TXG
|
-1.28 B | $ 22.43 | 1.72 % | $ 2.63 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
768 M | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
-55.8 M | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
-618 M | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
-485 M | - | - | $ 2.33 B | USA |
 |
NextGen Healthcare
NXGN
|
129 M | - | - | $ 1.6 B | USA |
 |
Health Catalyst
HCAT
|
-1.36 B | $ 1.45 | 16.0 % | $ 101 M | USA |
 |
OptimizeRx Corporation
OPRX
|
-64.3 M | $ 6.7 | 7.54 % | $ 115 M | USA |
 |
Schrödinger
SDGR
|
-629 M | $ 12.39 | 3.6 % | $ 910 M | USA |
 |
Phreesia
PHR
|
-799 M | $ 9.67 | 4.82 % | $ 578 M | USA |
 |
R1 RCM
RCM
|
-64.3 M | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
-16.4 B | $ 6.46 | 6.6 % | $ 1.14 B | USA |
 |
Signify Health
SGFY
|
-558 M | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-126 M | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
-1.12 B | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
-35.4 M | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
-2.06 B | $ 6.12 | -3.16 % | $ 98.2 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-408 M | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
109 M | $ 20.72 | -0.19 % | $ 630 M | USA |
 |
Omnicell
OMCL
|
383 M | $ 42.8 | 3.33 % | $ 1.97 B | USA |
 |
Progyny
PGNY
|
144 M | $ 18.6 | 0.11 % | $ 1.6 B | USA |
 |
So-Young International
SY
|
-1.17 B | $ 3.0 | -0.66 % | $ 234 M |  China |
 |
Zhongchao
ZCMD
|
-14.2 M | $ 2.13 | -1.39 % | $ 7.28 M | China |